|

DM002 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Xadcera Biopharmaceutical (Suzhou) Co., Ltd.1

Indications

  • Ovarian Neoplasms1
  • Prostatic Neoplasms1
  • Endometrial Neoplasms1
  • Solid Carcinoma1
  • Colorectal Neoplasms1

Oklahoma City, Oklahoma1 trial

A Study of DM002 in Patients With Advanced Solid Tumors

University of Oklahoma Health Sciences Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.